Related Experiment Video
Updated: Nov 16, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition
Michela Serresi1, Sonia Kertalli2, Lifei Li2
1Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany. michela.serresi@mdc-berlin.de gaetano.gargiulo@mdc-berlin.de.
Abstract:
Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state-specific therapy.
Insights
Chromatin regulators, not just kinases, significantly impact cancer cell plasticity during epithelial-mesenchymal transition (EMT). This study identifies key regulators controlling EMT and offers new therapeutic targets for lung cancer.
Area of Science:
- Cancer Biology
- Epigenetics
- Molecular Oncology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for cancer progression, involving proliferation, migration, and stress response.
- Kinase signaling is implicated as an EMT driver, but the full molecular mechanisms remain unclear.
- Understanding the regulators of EMT is vital for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of chromatin regulators in governing epithelial-mesenchymal interconversion.
- To compare the impact of chromatin regulators with kinases on EMT.
- To identify specific chromatin regulators involved in homeostatic EMT in lung cancer.
Main Methods:
- Pharmacological modulation of EMT.
- Synthetic genetic tracing.
- CRISPR interference screens to identify key genes.
- Analysis of chromatin regulators, kinases, RNAPII, and AP-1.
Main Results:
- Chromatin regulators have a broader impact on EMT than kinases.
- Several chromatin remodelers, writers, and readers were identified as key regulators of EMT in lung cancer.
- Loss of specific regulators like ARID1A, DOT1L, BRD2, and ZMYND8 showed complex effects on EMT.
- These regulators, along with RNAPII and AP-1, control enhancer chromatin of EMT signature genes.
Conclusions:
- Chromatin regulators play a significant role in controlling cancer cell plasticity and EMT.
- The identified regulators provide a platform for exploring novel therapeutic strategies targeting tumor-state-specific treatments.
- This research broadens the understanding of transcriptional control in cancer progression.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Spreading of Chromatin Modifications
Writers
The writer...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Master Transcription Regulators

